Ibotta [IBTA] vs Eplus [PLUS] Detailed Stock Comparison
Ibotta
NYSE
Loading...
Eplus
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ibotta wins in 6 metrics, Eplus wins in 12 metrics, with 0 ties. Eplus appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ibotta | Eplus | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 6.62 | 17.35 | Ibotta |
| Price-to-Book Ratio | 2.16 | 1.87 | Eplus |
| Debt-to-Equity Ratio | 7.22 | 12.68 | Ibotta |
| PEG Ratio | -0.06 | 0.45 | Ibotta |
| EV/EBITDA | 14.62 | 8.51 | Eplus |
| Profit Margin (TTM) | 26.24% | 5.45% | Ibotta |
| Operating Margin (TTM) | 2.09% | 6.55% | Eplus |
| EBITDA Margin (TTM) | 2.09% | 6.55% | Eplus |
| Return on Equity | 27.03% | 11.42% | Ibotta |
| Return on Assets (TTM) | 3.75% | 5.39% | Eplus |
| Free Cash Flow (TTM) | $105.72M | $295.54M | Eplus |
| Dividend Yield | N/A | 0.36% | N/A |
| 1-Year Return | -52.89% | -24.58% | Eplus |
| Price-to-Sales Ratio (TTM) | 1.85 | 0.89 | Eplus |
| Enterprise Value | $540.06M | $1.53B | Eplus |
| EV/Revenue Ratio | 1.47 | 0.71 | Eplus |
| Gross Profit Margin (TTM) | 79.16% | 23.26% | Ibotta |
| Revenue per Share (TTM) | $12 | $82 | Eplus |
| Earnings per Share (Diluted) | $4.07 | $4.18 | Eplus |
| Beta (Stock Volatility) | N/A | 1.14 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ibotta vs Eplus Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ibotta | 5.77% | -1.54% | -27.52% | -45.86% | -19.32% | -59.57% |
| Eplus | -0.81% | -1.75% | 5.51% | 1.76% | 12.41% | -2.20% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ibotta | -52.89% | -72.51% | 6.27% | 6.27% | 6.27% | 6.27% |
| Eplus | -24.58% | 57.43% | 90.50% | 288.25% | 1,439.79% | 2,168.65% |
Performance & Financial Health Analysis: Ibotta vs Eplus
| Metric | IBTA | PLUS |
|---|---|---|
| Market Information | ||
| Market Cap | $680.54M | $1.93B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 687,010 | 133,665 |
| 90 Day Avg. Volume | 693,577 | 170,975 |
| Last Close | $26.94 | $72.37 |
| 52 Week Range | $22.50 - $79.80 | $53.83 - $106.98 |
| % from 52W High | -66.24% | -32.35% |
| All-Time High | $117.59 (Apr 15, 2024) | $106.98 (Nov 04, 2024) |
| % from All-Time High | -77.09% | -32.35% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.19% |
| Quarterly Earnings Growth | -0.02% | 0.38% |
| Financial Health | ||
| Profit Margin (TTM) | 0.26% | 0.05% |
| Operating Margin (TTM) | 0.02% | 0.07% |
| Return on Equity (TTM) | 0.27% | 0.11% |
| Debt to Equity (MRQ) | 7.22 | 12.68 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $12.48 | $38.70 |
| Cash per Share (MRQ) | $8.82 | $18.21 |
| Operating Cash Flow (TTM) | $107.25M | $106.05M |
| Levered Free Cash Flow (TTM) | $66.33M | $200.10M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.36% |
| Last 12-Month Dividend | N/A | $0.25 |
Valuation & Enterprise Metrics Analysis: Ibotta vs Eplus
| Metric | IBTA | PLUS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 6.62 | 17.35 |
| Forward P/E | 9.87 | 12.36 |
| PEG Ratio | -0.06 | 0.45 |
| Price to Sales (TTM) | 1.85 | 0.89 |
| Price to Book (MRQ) | 2.16 | 1.87 |
| Market Capitalization | ||
| Market Capitalization | $680.54M | $1.93B |
| Enterprise Value | $540.06M | $1.53B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.47 | 0.71 |
| Enterprise to EBITDA | 14.62 | 8.51 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.14 |
| Book Value per Share (MRQ) | $12.48 | $38.70 |
Financial Statements Comparison: Ibotta vs Eplus
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IBTA | PLUS |
|---|---|---|
| Revenue/Sales | $84.57M | $637.32M |
| Cost of Goods Sold | $17.09M | $489.10M |
| Gross Profit | $67.48M | $148.22M |
| Research & Development | $18.07M | N/A |
| Operating Income (EBIT) | $-2.80M | $36.20M |
| EBITDA | $-638,000 | $43.61M |
| Pre-Tax Income | $483,000 | $36.81M |
| Income Tax | $-72,000 | $9.68M |
| Net Income (Profit) | $555,000 | $37.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IBTA | PLUS |
|---|---|---|
| Cash & Equivalents | $297.13M | $389.38M |
| Total Current Assets | $527.99M | $1.36B |
| Total Current Liabilities | $196.50M | $797.88M |
| Long-Term Debt | $24.51M | $11.32M |
| Total Shareholders Equity | $401.28M | $977.62M |
| Retained Earnings | $-139.89M | $850.96M |
| Property, Plant & Equipment | $25.21M | $22.63M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IBTA | PLUS |
|---|---|---|
| Operating Cash Flow | $28.13M | $175.76M |
| Capital Expenditures | $-1.89M | $-1.55M |
| Free Cash Flow | $14.89M | $159.09M |
| Debt Repayment | N/A | $-2.21M |
| Common Stock Repurchase | $-69.78M | $-13.48M |
Short Interest & Institutional Ownership Analysis
| Metric | IBTA | PLUS |
|---|---|---|
| Shares Short | 1.80M | 773,044 |
| Short Ratio | 2.85 | 4.18 |
| Short % of Float | 0.16% | 0.03% |
| Average Daily Volume (10 Day) | 687,010 | 133,665 |
| Average Daily Volume (90 Day) | 693,577 | 170,975 |
| Shares Outstanding | 30.95M | 26.53M |
| Float Shares | 12.84M | 25.84M |
| % Held by Insiders | 0.44% | 0.02% |
| % Held by Institutions | 0.53% | 0.99% |
Dividend Analysis & Yield Comparison: Ibotta vs Eplus
| Metric | IBTA | PLUS |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.25 |
| Last 12-Month Dividend Yield | N/A | 0.36% |
| 3-Year Avg Annual Dividend | N/A | $0.08 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | $0.25 |
| Ex-Dividend Date | N/A | Aug 26, 2025 |